About 3,370 results
Any time
Open links in new tab
Canadian Migraine Sufferers Have New Treatment …
WEBNov 16, 2022 · UBRELVY® is the first oral CGRP receptor antagonist (gepant) approved by Health Canada for the acute treatment of migraine. It reduces or eliminates migraine pain with a single tablet, with the ...
Latest Health, Healthcare News and Press Releases - Newswire
Press Release Distribution Service | Newswire
Health Canada Approves AbbVie's RINVOQ® (upadacitinib) for …
Wegovy® (semaglutide injection) available in Canada - Newswire
Health Canada Authorizes POLIVY® (polatuzumab vedotin for
Cision | News Releases - Newswire
All News Releases | Cision Canada - Newswire
QULIPTA™ Now Approved by Health Canada for the Preventive
RBC completes acquisition of HSBC Bank Canada - Newswire